CEL-SCI CORPORATION (CVM) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -22.29M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 14.80M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-22.29M | (m) | (m) | $14.80M | (m) | (m) |
| 2026-03-31 | $-22.22M | (m) | (m) | $14.89M | (m) | (m) |
| 2025-12-31 | $-23.29M | (m) | (m) | $15.13M | (m) | (m) |
| 2025-09-30 | $-24.81M | (m) | (m) | $15.89M | (m) | (m) |
| 2025-06-30 | $-24.90M | (m) | (m) | $16.66M | (m) | (m) |
| 2025-03-31 | $-26.08M | (m) | (m) | $17.62M | (m) | (m) |
| 2024-12-31 | $-26.76M | (m) | (m) | $18.24M | (m) | (m) |
| 2024-09-30 | $-26.35M | (m) | (m) | $18.16M | (m) | (m) |
| 2024-06-30 | $-27.70M | (m) | (m) | $18.95M | (m) | (m) |
| 2024-03-31 | $-29.21M | (m) | (m) | $19.98M | (m) | (m) |
| 2023-12-31 | $-30.31M | (m) | (m) | $21.43M | (m) | (m) |
| 2023-09-30 | $-31.48M | (m) | (m) | $22.47M | (m) | (m) |
| 2023-06-30 | $-32.96M | (m) | (m) | $23.67M | (m) | (m) |
| 2023-03-31 | $-33.49M | (m) | (m) | $24.22M | (m) | (m) |
| 2022-12-31 | $-34.87M | (m) | (m) | $24.66M | (m) | (m) |
| 2022-09-30 | $-36.06M | (m) | (m) | $25.36M | (m) | (m) |
| 2022-06-30 | $-35.59M | (m) | (m) | $24.18M | (m) | (m) |
| 2022-03-31 | $-37.33M | (m) | (m) | $25.08M | (m) | (m) |
| 2021-12-31 | $-36.31M | (m) | (m) | $23.78M | (m) | (m) |
| 2021-09-30 | $-36.19M | (m) | (m) | $23.11M | (m) | (m) |
| 2021-06-30 | $-36.17M | (m) | (m) | $22.98M | (m) | (m) |
| 2021-03-31 | $-32.67M | (m) | (m) | $19.77M | (m) | (m) |
| 2020-12-31 | $-30.86M | (m) | (m) | $19.00M | (m) | (m) |
| 2020-09-30 | $-28.99M | (m) | (m) | $17.84M | (m) | (m) |
| 2020-06-30 | $-26.02M | (m) | (m) | $15.90M | (m) | (m) |
| 2020-03-31 | $-24.32M | (m) | (m) | $14.95M | (m) | (m) |
| 2019-12-31 | $-21.96M | (m) | (m) | $13.38M | (m) | (m) |
| 2019-09-30 | $-20.20M | (m) | (m) | $12.66M | (m) | (m) |
| 2019-06-30 | $-18.08M | (m) | (m) | $9.64M | (m) | (m) |
| 2019-03-31 | $-16.96M | (m) | (m) | $9.77M | (m) | (m) |
| 2018-12-31 | $-16.88M | (m) | (m) | $10.21M | (m) | (m) |
| 2018-09-30 | $-16.77M | (m) | (m) | $9.40M | (m) | (m) |
| 2018-06-30 | $-16.92M | (m) | (m) | $10.01M | (m) | (m) |
| 2018-03-31 | $-17.61M | (m) | (m) | $10.77M | (m) | (m) |
| 2017-12-31 | $-21.31M | (m) | (m) | $14.38M | (m) | (m) |
| 2017-09-30 | $-21.34M | (m) | (m) | $15.61M | (m) | (m) |
| 2017-06-30 | $-26.15M | (m) | (m) | $19.45M | (m) | (m) |
| 2017-03-31 | $-27.29M | (m) | (m) | $20.63M | (m) | (m) |
| 2016-12-31 | $-25.18M | (m) | (m) | $18.21M | (m) | (m) |
| 2016-09-30 | $-25.55M | (m) | (m) | $19.35M | (m) | (m) |
| 2016-06-30 | $-26.78M | (m) | (m) | $19.88M | (m) | (m) |
| 2016-03-31 | $-28.60M | (m) | (m) | $20.77M | (m) | (m) |
| 2015-12-31 | $-30.08M | (m) | (m) | $21.24M | (m) | (m) |
| 2015-09-30 | $-34.30M | (m) | (m) | $20.95M | (m) | (m) |
| 2015-06-30 | $-34.47M | (m) | (m) | $19.96M | (m) | (m) |
| 2015-03-31 | $-33.17M | (m) | (m) | $18.72M | (m) | (m) |
| 2014-12-31 | $-31.64M | (m) | (m) | $17.84M | (m) | (m) |
| 2014-09-30 | $-27.57M | $264.03K | (m) | $17.00M | (m) | -10443.43% |
| 2014-06-30 | $-24.13M | (m) | (m) | $16.10M | (m) | (m) |
| 2014-03-31 | $-22.75M | (m) | (m) | $15.42M | (m) | (m) |
| 2013-12-31 | $-20.76M | (m) | (m) | $13.78M | (m) | (m) |
| 2013-09-30 | $-19.87M | $159.58K | (m) | $12.68M | (m) | -12450.12% |
| 2013-06-30 | $-19.12M | (m) | (m) | $12.06M | (m) | (m) |
| 2013-03-31 | $-17.82M | (m) | (m) | $10.37M | (m) | (m) |
| 2012-12-31 | $-17.84M | (m) | (m) | $10.84M | (m) | (m) |
| 2012-09-30 | $-17.24M | $254.61K | (m) | $10.37M | (m) | -6772.26% |
| 2012-06-30 | $-16.65M | (m) | (m) | $10.03M | (m) | (m) |
| 2012-03-31 | $-17.28M | (m) | (m) | $10.49M | (m) | (m) |
| 2011-12-31 | $-18.11M | (m) | (m) | $10.94M | (m) | (m) |
| 2011-09-30 | $-17.99M | (m) | (m) | $11.75M | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | $-18.56M | (m) | (m) | $11.91M | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | $-12.02M | (m) | (m) | $6.01M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |